Anja Stein

Dr. Anja Stein

Universität Duisburg-Essen
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2002 in Nature Genetics
Verified
Journal Article
Closed access
CBCornelius F. Boerkoel
Cornelius F. Boerkoel
HTHiroshi Takashima
Hiroshi Takashima
JJJoy John
Joy John
JYJiong Yan
Jiong Yan
PSPawel Stankiewicz
Pawel Stankiewicz
DSDavid W. Stockton
David W. Stockton

11 August 2020 in JAMA
Verified
Journal Article
Open access
PDF file
AFAxel R. Franz
Axel R. Franz
CECorinna Engel
Corinna Engel
DBDirk Bassler
Dirk Bassler
MRMario Rüdiger
Mario Rüdiger
UTUlrich H. Thome
Ulrich H. Thome
RPRenáta Polácková
Renáta Polácková
It has been estimated that between 1990 and 2016, the overall burden from prematurity-related morbidity, including brain injury, measured as years lived with disability, had the largest increase among all common causes of disability.1

17 February 2016 in Brain
Verified
Journal Article
Open access
PDF file
SBSusan Byrne
Susan Byrne
LJLara Jansen
Lara Jansen
JUJean-Marie U-King-Im
Jean-Marie U-King-Im
ASAta Siddiqui
Ata Siddiqui
HLHart G. W. Lidov
Hart G. W. Lidov
HJHeinz Jungbluth
Heinz Jungbluth
Vici syndrome is a progressive neurodevelopmental multisystem disorder due to recessive mutations in the key autophagy gene EPG5. We report genetic, clinical, neuroradiological, and neuropathological features of 50 children from 30 families, as well as the neuronal phenotype of EPG5 knock-down in Drosophila melanogaster. We identified 39 different EPG5 mutations, most of them truncating and predicted to result in reduced EPG5 protein. Most mutations were private, but three recurrent mutations (p.Met2242Cysfs*5, p.Arg417*, and p.Gln336Arg) indicated possible founder effects. Presentation was mainly neonatal, with marked hypotonia and feeding difficulties. In addition to the five principal features (callosal agenesis, cataracts, hypopigmentation, cardiomyopathy, and immune dysfunction), we identified three equally consistent features (profound developmental delay, progressive microcephaly, and failure to thrive). The manifestation of all eight of these features has a specificity of 97%, and a sensitivity of 89% for the presence of an EPG5 mutation and will allow informed decisions about genetic testing. Clinical progression was relentless and many children died in infancy. Survival analysis demonstrated a median survival time of 24 months (95% confidence interval 0–49 months), with only a 10th of patients surviving to 5 years of age. Survival outcomes were significantly better in patients with compound heterozygous mutations (P = 0.046), as well as in patients with the recurrent p.Gln336Arg mutation. Acquired microcephaly and regression of skills in long-term survivors suggests a neurodegenerative component superimposed on the principal neurodevelopmental defect. Two-thirds of patients had a severe seizure disorder, placing EPG5 within the rapidly expanding group of genes associated with early-onset epileptic encephalopathies. Consistent neuroradiological features comprised structural abnormalities, in particular callosal agenesis and pontine hypoplasia, delayed myelination and, less frequently, thalamic signal intensity changes evolving over time. Typical muscle biopsy features included fibre size variability, central/internal nuclei, abnormal glycogen storage, presence of autophagic vacuoles and secondary mitochondrial abnormalities. Nerve biopsy performed in one case revealed subtotal absence of myelinated axons. Post-mortem examinations in three patients confirmed neurodevelopmental and neurodegenerative features and multisystem involvement. Finally, downregulation of epg5 (CG14299) in Drosophila resulted in autophagic abnormalities and progressive neurodegeneration. We conclude that EPG5-related Vici syndrome defines a novel group of neurodevelopmental disorders that should be considered in patients with suggestive features in whom mitochondrial, glycogen, or lysosomal storage disorders have been excluded. Neurological progression over time indicates an intriguing link between neurodevelopment and neurodegeneration, also supported by neurodegenerative features in epg5-deficient Drosophila, and recent implication of other autophagy regulators in late-onset neurodegenerative disease.

22 January 2007 in Human Mutation
Verified
Journal Article
Closed access
PDF file
JCJ. Marietta Clewing
J. Marietta Clewing
HFHelen Fryssira
Helen Fryssira
DGDavid Goodman
David Goodman
SSSarah F. Smithson
Sarah F. Smithson
ESEmily A. Sloan
Emily A. Sloan
CBCornelius F. Boerkoel
Cornelius F. Boerkoel
Schimke immunoosseous dysplasia (SIOD), which is characterized by prominent spondyloepiphyseal dysplasia, T‐cell deficiency, and focal segmental glomerulosclerosis, is a panethnic autosomal recessive multisystem disorder with variable expressivity. Biallelic mutations in switch/sucrose nonfermenting (swi/snf) &!ndash;related, matrix‐associated, actin‐dependent regulator of chromatin, subfamily a‐like 1 (SMARCAL1) are the only identified cause of SIOD. However, among 72 patients from different families, we identified only 38 patients with biallelic mutations in the coding exons and splice junctions of the SMARCAL1 gene. This observation, the variable expressivity, and poor genotype–phenotype correlation led us to test several hypotheses including modifying haplotypes, oligogenic inheritance, or locus heterogeneity in SIOD. Haplotypes associated with the two more common mutations, R820H and E848X, did not correlate with phenotype. Also, contrary to monoallelic SMARCAL1 coding mutations indicating oligogenic inheritance, we found that all these patients did not express RNA and/or protein from the other allele and thus have biallelic SMARCAL1 mutations. We hypothesize therefore that the variable expressivity among patients with biallelic SMARCAL1 mutations arises from environmental, genetic, or epigenetic modifiers. Among patients without detectable SMARCAL1 coding mutations, our analyses of cell lines from four of these patients showed that they expressed normal levels of SMARCAL1 mRNA and protein. This is the first evidence for nonallelic heterogeneity in SIOD. From analysis of the postmortem histopathology from two patients and the clinical data from most patients, we propose the existence of endophenotypes of SIOD. Hum Mutat 28(3), 273–283, 2007. Published 2006, Wiley‐Liss, Inc.

22 March 2012 in Klinische Padiatrie
Verified
Journal Article
Closed access
PDF file
GSG. Stichtenoth
G. Stichtenoth
MDM. Demmert
M. Demmert
BBB. Bohnhorst
B. Bohnhorst
Anja SteinAnja Stein
Anja Stein
SES. Ehlers
S. Ehlers
CHC. Härtel
C. Härtel
The German Neonatal Network (GNN) is a prospective cohort study with the focus on long term development of very-low-birth-weight infants. It was the aim of this study to determine detailed information on causes of mortality in the GNN birth cohort 2010.Major contributors to hospital mortality were recorded by the attending neonatologists for the cohort of very-low-birth-weight (VLBW) infants born in centres of the German Neonatal Network (GNN) in 2010. The data quality was approved by on-site monitoring.2 221 VLBW infants were born in GNN centres in 2010, and death occurred in 221 infants. Male infants carried a higher risk than females (58.8% males among non-survivors vs. 51.7% among survivors, p=0.047). In 11 infants, the major contributor to death was not determined by the attending neonatologist. In 25 infants born at the limit of viability, comfort palliative care was primarily initiated and 14 infants had lethal malformations. The majority of non-survivors suffered from inflammatory diseases including sepsis- or necrotizing enterocolitis (NEC)-associated death (n=56). Respiratory pathology was a major contributor to death in 65 infants including 11 infants who died from pulmonary haemorrhage.Potentially preventable complications of preterm birth such as sepsis, NEC and pulmonary haemorrhage predominate the major contributors to mortality in the GNN 2010 cohort. In order to decrease the rate of these associated deaths, future trials should focus on prophylaxis and therapy optimization strategies for these outcomes.

1 February 2016 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
PDF file
CHChristoph Härtel
Christoph Härtel
AHAnnika Hartz
Annika Hartz
JPJulia Pagel
Julia Pagel
JRJan Rupp
Jan Rupp
Anja SteinAnja Stein
Anja Stein
GNGerman Neonatal Network
German Neonatal Network
Background. NOD2 loss-of-function mutations, that is, R702W [rs2066844], G908R [rs2066845], and Leu1007fsinsC [rs5743293], have been linked to inflammatory bowe